An interventional study of MCC/MCC-T and Standard gastroscopy in Upper Gastrointestinal Symptoms, sponsored by AnX Robotica Corp.. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-27.
Sponsored by AnX Robotica Corp. · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
A prospective single blinded, tandem study, comparing a magnetically controlled capsule with or without a tether (MCC or MCC-T) with conventional upper endoscopy for the diagnosis of patients with upper abdominal symptoms.
In the US patients commonly undergo esophagogastroduodenoscopy (EGD) for upper abdominal symptoms to try to resolve whether they have gastroesophageal reflux disease or functional dyspepsia, if they are older than the age of 60 with symptoms, or have alarm symptoms such as unexplained weight loss, persistent nausea and vomiting or if they have symptoms that are refractory to acid suppression therapy. Given the increasing burden of digestive disease in the US, the use of EGD is increasing in volume nationwide. EGD usually requires either conscious sedation or monitored anesthesia sedation, which has put an additional cost burden on the healthcare system. Since MCC or MCC-T does not require sedation, it offers an attractive option for both patients and clinicians alike.
The aim of this study is to compare in the same patient the accuracy of the MCC and MCC-T and EGD in patients presenting with upper abdominal symptoms.
AnX Robotica Corp. is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients are assigned to swallow a magnetically controlled capsule first then undergo standard gastroscopy
Device: MCC/MCC-T · Device: Standard gastroscopy
Magnetically controlled capsule endoscopy (MCC), with or without tether, is used to visualize the upper gastrointestinal tract
Also known as: Magnetic controlled capsule endoscopy with/without tether
Diagnostic endoscopic procedure that visualizes the upper part of the gastrointestinal tract down to the duodenum
Also known as: EGD
Compare Total Number of Lesions Identified Via MCCE Versus EGD
A count of the cumulative total number of lesions identified by the MCCE procedure versus a count of the cumulative total number of lesions identified by the EGD procedure.
Time frame: Day of EGD procedure
Number of Adverse Events
Occurrence and severity of adverse event related to MCCE procedure versus EGD procedure. Outcomes noted in AE/SAE sections. Adverse Events were NOT collected in the Healthy Volunteer arm.
Time frame: 24-72 hour follow up phone call post EGD procedure
Participant Satisfaction Score With MCCE Procedure Versus EGD Procedure
Participant acceptance of MCCE versus EGD (units on a scale, scale of 1 to 10; when 1 is the lowest and 10 is the highest score)
Time frame: 24-72 hour follow up phone call post EGD procedure
To Compare Rate of Complete Examination for the MCC and EGD Procedures
Total count of participants who were able to complete their MCC procedure, compared to a total count of participants able to complete their EGD procedure.
Time frame: Day of procedure
11 healthy volunteers had the MCCE procedure for training purposes only, they did not have the EGD procedure; demographic data was collected, however outcome data was not collected or analyzed
| Milestone | Single Arm Tandem Procedures | Healthy Volunteers |
|---|---|---|
| Started | 16 | 11 |
| Completed | 16 | 11 |
| Not completed | 0 | 0 |
A count of the cumulative total number of lesions identified by the MCCE procedure versus a count of the cumulative total number of lesions identified by the EGD procedure.
| # of lesions identified | MCC Procedure | EGD Procedure |
|---|---|---|
| Compare Total Number of Lesions Identified Via MCCE Versus EGD | 10 | 12 |
Occurrence and severity of adverse event related to MCCE procedure versus EGD procedure. Outcomes noted in AE/SAE sections. Adverse Events were NOT collected in the Healthy Volunteer arm.
| events | Single Arm Tandem Procedures |
|---|---|
| # of AEs identified with MCC | 1 |
| # of AEs identified with EGD | 2 |
Participant acceptance of MCCE versus EGD (units on a scale, scale of 1 to 10; when 1 is the lowest and 10 is the highest score)
| units on a scale | Single Arm Tandem Study |
|---|---|
| Satisfaction with MCCE procedure | 8.13 ± 2.33 |
| Satisfaction with EGD procedure | 7.56 ± 2.66 |
Total count of participants who were able to complete their MCC procedure, compared to a total count of participants able to complete their EGD procedure.
| participants | MCC Procedure | EGD Procedure |
|---|---|---|
| To Compare Rate of Complete Examination for the MCC and EGD Procedures | 16 | 16 |
Collected over Participants were followed in this study for 24-72 hours post the EGD procedure. Any open AEs to be followed by the prescribing physician.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Single Arm Tandem Procedures | 0/16 (0%) | 0/16 (0%) | 3/16 (18.8%) |
| Event | Single Arm Tandem Procedures |
|---|---|
| abdominal cramping with MCCE procedureGastrointestinal disorders | 1/3 |
| vomiting with EGD procedureGastrointestinal disorders | 1/16 |
| acid reflux with EGD procedureGastrointestinal disorders | 1/16 |
Participants had MCCE procedure followed by an EGD procedure
| Age, Continuous(years) | Single Arm Tandem Procedures | Healthy Volunteers | Total |
|---|---|---|---|
| Median | 49.25 ± 13.77 | 52.45 ± 7.90 | 50.56 ± 11.66 |
| Sex: Female, Male(Participants) | Single Arm Tandem Procedures | Healthy Volunteers | Total |
|---|---|---|---|
| Female | 9 | 7 | 16 |
| Male | 7 | 4 | 11 |
| Ethnicity (NIH/OMB)(Participants) | Single Arm Tandem Procedures | Healthy Volunteers | Total |
|---|---|---|---|
| Hispanic or Latino | 2 | 0 | 2 |
| Not Hispanic or Latino | 11 | 11 | 22 |
| Unknown or Not Reported | 3 | 0 | 3 |
| Race (NIH/OMB)(Participants) | Single Arm Tandem Procedures | Healthy Volunteers | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 0 | 2 | 2 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 1 | 0 | 1 |
| White | 15 | 9 | 24 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Population(Participants) | Single Arm Tandem Procedures | Healthy Volunteers | Total |
|---|---|---|---|
| Count of participants | 16 | 11 | 27 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Feb 2021 to primary completion in Jun 2021, 4 months.
Results were first posted in May 2026, 4 years 10 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
AnX Robotica Corp.